According to a report by an international peer review committee, the Academy’s Hubrecht Institute for Developmental Biology and Stem Cell Research is even better now than it was six years ago, the last time it underwent an assessment. The institute is world leading, comparable in quality to MIT and Germany’s European Molecular Biology Laboratory (EMBL).
The committee was impressed by the institute’s scientific output and the quality of its research (it achieved an impact score of 2.9 in the past ten years), and praises both its new collaborative initiatives and its dynamic academic environment. The latter was confirmed by the PhD students and postdocs working at the institute.
The Academy is pleased with the review committee’s opinion and will adopt most of its recommendations. It will investigate whether the institute’s funding can be brought into line with its international standing.
The Hubrecht Institute will work on maintaining a good balance between basic research and the demands of the clinic and society. It will also provide more structural assistance to young researchers. Both the institute and the Academy will take steps to improve the process of technology transfer.
About the Hubrecht Institute
The Hubrecht Institute is a research institute of the Royal Netherlands Academy of Arts and Sciences. Presently there are 20 research groups with a total of about 200 employees. In addition to a highly interactive and international scientific environment, excellent research facilities are available for imaging and functional genomics. Moreover, several model organisms are present, including C. elegans, zebrafish and mice. The institute is situated in Utrecht at the university centre De Uithof. The Hubrecht Institute is affiliated with the University Medical Center Utrecht and has close connections with Utrecht University, e.g. in the Graduate School Cancer Genomics and Development Biology.